Clinical Trials Logo

Clinical Trial Summary

Dyslexia, an impairment in accurate or fluent word recognition, is the most common learning disability affecting roughly ten percent of children. This proposal capitalizes on cutting edge neuroimaging methods, in combination with reading education programs, to generate a new understanding of how successful reading education shapes the development of the brain circuits that support skilled reading. A deeper understanding of the mechanisms of successful remediation of dyslexia, and individual differences in learning, will pave the way for personalized approaches to dyslexia treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04323488
Study type Interventional
Source Stanford University
Contact
Status Enrolling by invitation
Phase N/A
Start date May 1, 2021
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04028310 - Developmental Dyslexia and Remediation Methods N/A
Recruiting NCT04122820 - Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD). N/A
Recruiting NCT04287530 - Poly-unsaturated Fatty Acids and Developmental Dyslexia N/A
Completed NCT04041960 - Effects of TBS on Reading in Adult Struggling Readers N/A
Recruiting NCT06261307 - Language Development Deficits and Early Interactive Music Intervention N/A
Recruiting NCT05373576 - Neurofunctional Correlates of the Behavioral Modifications Associated With Tachidino in Children With Developmental Dyslexia N/A
Recruiting NCT06387615 - Impact of Non-invasive Brain Stimulation on Learning Novel Spoken Words N/A
Not yet recruiting NCT06403007 - Tackling Two of the Most Important Unresolved Tasks in Reading Intervention N/A